Ansa Biotechnologies, Inc.’s Post

🔊 Big news! We are expanding our early access program! More customers around the world will now be able to take advantage of our company’s innovative enzymatic DNA synthesis technology for complex DNA synthesis services. A few highlights from the early access program include complex DNA products that allowed customers to: ✔ Manufacture sequences with strong secondary structures and an extreme range of GC content to advance research related to microbial gene transfer and communities ✔ Synthesize highly repetitive spider silk genes for the creation of new materials with a wide range of important applications ✔ Create all constituent DNA parts required to assemble a complete, high-GC bacteriophage genome for the identification and engineering of potential therapeutic agents ✔ Rapidly produce protein-coding sequences with tandem repeats to accelerate the development of treatments that can help delay the onset of age-related illnesses Additional details here: https://lnkd.in/ey6gDRyg Want to find out even more? Ansa is a proud sponsor of the Global Synthetic Biology (#SynBioBeta2024) Conference this week in San Jose, Calif. Meeting attendees will be able to hear from current customers and learn how to participate in the company’s expanded early access program throughout the conference in Booth 312 #DNAsynthesis #longDNA #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA #customDNA #AnsamerAnswers

Early Access

Early Access

https://ansabio.com

Nicolas Krink

CEO & Co-founder at BioHalo | Making an impact for disruptive innovation at SPRIND

4mo
Like
Reply

To view or add a comment, sign in

Explore topics